HIGHLIGHTS
SUMMARY
Triple-negative breast cancer (TNBC) is regarded as the most aggressive breast cancer, and it is immunohistochemically defined by the negative expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. To date, whether radiomics features can differentiate TNBC and fibroadenoma and combined conventional the authors features and clinical findings can improve the predictive values for distinguishing TNBC from fibroadenoma have not been systematically investigated. In the present research, the authors developed a Rad-score consisting of 12 radiomic features to differentiate TNBC from fibroadenoma, and the Rad-score demonstrated sufficient . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.